COTY · COTY INC · Stock research

Current Thesis

Coty is a highly-levered prestige and mass beauty operator (Gucci and Burberry fragrance licenses, CoverGirl, Rimmel, Marc Jacobs, Sally Hansen) trading as a distressed turnaround, not a growth story. The late-July 2026 tape is a countertrend bounce: a ~22.8% six-day rally into 2026-07-22 (Trefis) off the ~$1.82 all-time low set 2026-06-29, retracing a sliver of a -60% one-year drawdown from the $5.33 high. What an investor is actually buying here is de-levering — the ~$400M Gucci beauty license transition back to Kering (announced 2026-07-07) is cash against a $3.17B net-debt load, and management has stated a path from ~3.3-3.4x net-debt/EBITDA toward ~2x. The counter is that the rally is explicitly disconnected from fundamentals (Q3 FY26 like-for-like sales -7%, revenue $1.28B, -1.3% YoY) and the whole trade re-prices on the Q4/full-year print due ~2026-08-19. This is a value-adjacent bounce inside a broken downtrend, not an accelerating narrative with peer cluster confirmation.

Bullish and bearish views on COTY INC

The model's bull view on COTY INC (COTY), in brief: De-lever catalyst is live. The ~$400M Gucci beauty license transition back to Kering (announced 2026-07-07) delivers cash against $3.43B gross / ~$3.17B net debt; management targets net leverage toward ~2x from the current ~3.3-3.4x. Self-help cost-out underway. The 2026-07-02… The bear view: Rally outran the business. Trefis (2026-07-22) flags the +22.8% move as disconnected from fundamentals; revenue is down ~3.6% on a trailing-twelve-month basis. Weak Q3 FY26 core. Revenue $1.28B (-1.3% YoY), like-for-like -7% on Middle East / travel-retail disruption, gross… Both cases follow in full.

Bull Case

• De-lever catalyst is live. The ~$400M Gucci beauty license transition back to Kering (announced 2026-07-07) delivers cash against $3.43B gross / ~$3.17B net debt; management targets net leverage toward ~2x from the current ~3.3-3.4x.
• Self-help cost-out underway. The 2026-07-02 reorganization merged Prestige R&D and sustainability into supply chain under interim leadership, a simplification aimed at margin recapture after adj. Gross margin fell to 61.8% (-250bps YoY) in Q3 FY26.
• Product and flow flickers. The Marc Jacobs Beauty relaunch and an index-inclusion move around 2026-06-12 gave the tape a near-term bid.
• Valuation reset with an open upside PT. At roughly $2.55-$2.70 the stock sits below the ~$3.17-$3.70 consensus target, with Evercore ISI still at $7 Outperform (cut from $10) against Barclays' $3.50 Underweight — a wide dispersion that resolves violently on the print.
• Cash engine intact. FY26 guidance still calls for ~$838-848M adjusted EBITDA and $0.33-0.35 adjusted EPS ex-equity-swap; the business is levered, not broken.
• Low-float optics. A sub-$3 handle plus 43.25M shares short (~4.9%) means any clean beat gaps hard.

Bear Case

• Rally outran the business. Trefis (2026-07-22) flags the +22.8% move as disconnected from fundamentals; revenue is down ~3.6% on a trailing-twelve-month basis.
• Weak Q3 FY26 core. Revenue $1.28B (-1.3% YoY), like-for-like -7% on Middle East / travel-retail disruption, gross margin -250bps — demand is soft where it matters.
• Thin Q4 guide. Q4 FY26 adjusted EBITDA guided $85-95M and adjusted EPS breakeven to -$0.02 (ex-swap); little cushion if beauty demand stays weak.
• Structural license attrition. Losing Gucci removes a top prestige revenue stream, and Kering Beauté's in-house build makes further license clawbacks a portfolio risk, not a one-off.
• Leadership overhang. Interim CEO Markus Strobel (Executive Chairman) per the 2026-07-02 release; no permanent CEO named — a search overhang on any re-rate.
• Balance sheet is the whole story. $3.17B net debt at ~3.3-3.4x means any EBITDA slip re-rates leverage the wrong way and pressures the equity first.

Setup & Price Structure

• Trading ~$2.55-$2.70 into 2026-07-23; StocksToTrade marks intraday support $2.53-$2.54 and resistance $2.70-$2.76.
• Bounce structure: +22.8% over six sessions into 2026-07-22 off the ~$1.82 all-time low (2026-06-29), forming short-term higher lows / higher highs.
• Longer frame remains broken: 52-week range $1.84-$5.33, -60% one-year, ~$2.4B market cap.
• The grind is a countertrend recovery leg inside a primary downtrend. Reclaiming and holding above $2.76 opens air toward the ~$3.17 consensus; losing the $2.50 shelf re-exposes the June low.
• For a momentum book, strength here is not the setup — it is a bounce off distressed lows into a binary print, so it reads as a small probe or a stand-aside until it either bases above $2.76 or the print de-risks the leverage.

Catalyst Calendar (next 30 days)

• ~2026-08-19 (est.): Q4 and full-year FY26 results and call — the binary. Bars to clear: Q4 adj. EBITDA $85-95M, FY $838-848M, and evidence that net leverage is trending toward 2x. Avoid fresh size into the print given -7% LFL momentum.

Elapsed catalysts

• Ongoing: Gucci beauty license transition close (~$400M, announced 2026-07-07) — watch for explicit debt-paydown / cash-application confirmation. (passed 33d ago)
• Ongoing: permanent-CEO announcement (interim since 2026-07-02) — a named operator could re-rate sentiment independent of the numbers. (passed 38d ago)

What Would Change Our Mind

• Upside confirmation: sustained daily closes above $2.76 that hold the shelf, ideally after the ~2026-08-19 print, would flip this from a countertrend bounce into a base worth sizing.
• Fundamental confirmation: an Aug-19 print showing net leverage ticking below 3.3x and like-for-like materially better than -7% would validate the de-lever thesis.
• Thesis break: a daily close below $2.30 forfeits the June-low bounce; a subsequent weekly close below $1.82 confirms the downtrend has resumed. A print that pushes net leverage back above 3.4x removes the entire reason to own it.

Correlation Notes

• Moves with beauty / consumer-discretionary peers — Estée Lauder (EL), e.l.f. (ELF), Ulta (ULTA); EL's own turnaround tape is the sector read-through.
• Kering (KER.PA) is now both counterparty (Gucci license transition) and competitor (Kering Beauté); Kering's in-house beauty build is a standing license-attrition risk to Coty.
• FX- and travel-retail-sensitive given large ex-US prestige exposure; Middle East demand was the explicit swing factor behind Q3 FY26's -7% LFL.
• Rate-sensitive through the debt load — a tightening macro regime pressures highly-levered turnarounds disproportionately, so this trades with the credit backdrop as much as with beauty demand.